Chinese scientists have created the world’s first pigs with a targeted edit in the LXRα gene, opening a new path for studying heart diseases in conditions closer to the human body.
The work comes from researchers at the Chinese Academy of Sciences (CAS), who say the model can change how scientists understand cholesterol, inflammation, and cardiovascular disorders.
The team, based at the Institute of Subtropical Agriculture under CAS, successfully produced four cloned pigs with precise edits in the liver X receptor alpha (LXRα) gene. This gene plays a key role in maintaining liver cell health and regulating how the body handles cholesterol and inflammation.
LXRα: A Gene That Controls More Than Cholesterol
LXRα is often described as a master regulator of cholesterol homeostasis. When it is altered, it does not just affect fat metabolism. It also changes how the immune system reacts and how inflammation develops in the body. By editing a single gene, the researchers observed wide-ranging biological effects in the pigs.
READ ALSO: Tufts University Creates Color-Changing Paint That Measures Impact Force Without Sensors
The project was led by Yin Yulong, along with key researchers Chen Jianwen and Xu Kui. The team used advanced gene-editing and cloning techniques to ensure that the LXRα gene was selectively modified in each animal.
The result is a new type of large-animal model that behaves more like a human body than traditional lab mice. Scientists have long relied on rodents to study diseases, but mice do not fully match human biology, especially in terms of heart structure, blood vessels, and fat metabolism.
Why These Pigs Matter For Human Health
“These pigs give us a clearer view of how metabolic problems lead to heart disease,” Chen Jianwen said. He explained that the model allows researchers to study how cholesterol buildup triggers inflammation in arteries, a major cause of conditions like atherosclerosis and heart attacks.
The LXRα-edited pigs showed clear changes in cholesterol metabolism. They also displayed shifts in immune signaling and inflammatory pathways. These combined effects make them highly valuable for studying the early stages of cardiovascular disease.
Researchers say this model fills a major gap in biomedical science. While small animals are useful for early-stage research, they often fail to predict how treatments will work in humans. Larger animals, such as pigs, offer a closer match, making results more reliable for clinical use.
WATCH ALSO: China’s military showcases modern battlefield capabilities in new exercise
The importance of LXRα in gene-editing research goes beyond this single study. Because it controls both metabolism and inflammation, it sits at the center of many chronic diseases. By editing this gene, scientists can better understand how disorders develop over time and how they might be stopped.
In human medicine, this approach could guide the design of new drugs that target cholesterol imbalance and inflammatory damage together. It may also help researchers test therapies in a more realistic biological setting before moving to human trials.
The team emphasized that this work is not just about creating a new animal model. It is about building a platform for future discoveries. With these pigs, scientists can explore how lifestyle, diet, and genetics interact to influence heart health.
They also plan to use the model to test new treatments. This includes drugs to reduce plaque buildup in arteries and therapies to control harmful inflammation.
READ ALSO: Pratt & Whitney Wins $3.8B Pentagon Deal to Supply F135 Engines for Global F-35 Fleet
“This model will support more precise and meaningful research,” Yin Yulong said. He added that it strengthens the role of large-animal studies in modern medicine and helps bridge the gap between lab research and real-world treatment.
The development also marks steady progress in gene-editing technology. It shows that scientists can now make highly specific genetic changes in larger animals, opening doors to more complex and accurate disease models.
As research continues, the LXRα gene-edited pigs are expected to play a central role in understanding cardiovascular diseases. They may also help shape the next generation of treatments, bringing science a step closer to more effective, personalized healthcare.
